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The concept of cellular typing by cell
mediated lympholysis (CML), in which
cytotoxic lymphocytes are used to identify
cell surface structures on target cells, has
emerged over the last decade as it has
become apparent that foreign structures on
target cells can be recognized by Τ cells
(Cerottini et al. 1979a, b, Sondel et al.
1975). It is not yet clear, nor should it be
assumed, that target molecules recognized
by CML are also recognizable by classical
antibody. Such a concordance or discor-
dance will only become apparent when
more is known of the immunological top-
ography of cell surface structures. Tentative
specificities, however, have been identified
by CML in man which have, as yet, not
been recognized by classical antibody
(Mawas et al. 1973, 1976, Kristensen et al.
1974, Goulmy et al. 1976, 1977, Bradley
et al. 1978). Moreover, one can generate
CML effector cells as reagents in vitro from
native orimmunizedPBL and more recently
it has become possible to propogate them
in long term culture and ultimately derive
clones (Bonnard et al. 1978, Charmot et al.
1979, Schendel et al, 1979a, Schendel &
Bonnard 1979, Malissen et al. 1979). These
+ Workshop held at: Institut für Immunologie der Universität München, Schillerstrasse 2, München,
W. Germany. June 28-29, 1979.
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Table 1
Seyologically defweä faretgn phenotypes Seen by tbe pnnied cells
Resp /Pnmary sumulator HLA Non-HLA
1/2
1/3
1/4
2/1
2/3
2/4
3/1
3/2
3/4
4/1
4/2
4/3
A2, 3,B5, 7,DRw2
A28, 3, B7, w35, Cw4, DRw7
A28, 3,B5, 7,DRw2
Awl9,B8, 14,DRw6
A28,Bw35,Cw4,DRw7
A28
Awl9, B8, B14, DRw3, wo
A2,B5,DRw2, w3
B5, Drw2, w3
Awl9, B8, B14, DRw6
A2
Bw35,Cw4,DRw7
M, S, k
c Ε, Μ, S, k
M, k
Α, Ν, Κ, Fya, Jka
c Ε, Ν, Fya, Jka
Fya, Jka
Υ, Α, s, K, Fyb
Y, s, Fyb
Y, s
Α, Ν, Κ, Fyb, Jk b
S, Fyb, Jkb
c E, N, S, ]k b
In Aarhus 300 ml hepannized blood were drawn from four selected donors (1, 2, 3 and 4) Mono-
nuclear cells were isolated on Ficoll, washed and frozen directly in serum 50%, RPMI 40% & DSMO
10% and stored at — 180°C in vials containing 6 X 10' cells in a total volume of 1 ml The cells were
not mitotically mactivated The four batches of cells were spht equally between the five participatmg
centers with a rmnimum of 11 tubes per individual to each center The cells were tested by local tech-
mques and there were consequently no technical restnctions
Phenotypes of Cells
1 HLA-Awl9,19, B8, B14 DRw3, w6
2 HLA-A2, 3,B5,B7,DRw2,w3
3 HLA-A28, 3,B7, w35,Cw4,DRw7
4 HLA-A28, 3, B5, 7, DRw2, 3
XY, A, CDe, N, s, Pl, Lub K, Leb Fy a b , Jk a b
XY, O, CDe, M, Ss, Pl, Lu , k, Le , Fyb, Jk b
XX.O.CcDEe, MN, S, Pl, Lub, k, Leb, Fya, Jk a b
XY, O, CDe, Μ s, Pl, Lub, k, Leb, Fya, ]k a
facts strengthen the belief that CML typing
can offer much more for lmmunogenetic
analysis than serological typing alone
Many aspects of the lymphocyte cul-
turmg for the generation of effector cells
and target cells and data analysis are
umque to the CML technique This CML
Workshop was orgamzed between several
interested parties in an atempt to standard-
lze them.
Atms of the Workshop
The aims were (1) To compare the results
obtained from testing a Standard set of
cells shipped from one center (Aarhus) to
four foreign Centers and to test these
frozen cells by local CML techmques of the
five different centers,
(2) To agree upon a standardized CML
technique,
(3) To investigate the feasibihty of
future multicenter collaborative studies,
with immunogenetics bemg the pnmary
concern.
Comparative analysis of local techmques
As with the previous Workshop (see
Knstensen 1978) the pnmary aim was the
standardization of established techmques
and not the apphcation of recent ιηηο-
vations. Nevertheless, one new area, which
was considered was that of Τ cell expansion
techmques designed to perpetuate and
expand specific cytolytic Τ cells in vitro,
thus generating cloned reagents in quanti-
ties which had hitherto not been available
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Table 2
Isotope labeling and counting procedures oftarget cells
"hus
spontaneous cpm
maximal cpm
total cpm
iden
irseille
ünchen
slo
Target 1
125
317
356
300
1.979
3.369
* 282
*2.634
5.940
116
1.278
1.247
483
1.479
Target 2
157
406
454
484
2.056
3.208
166
1.488
3.064
138
1.207
1.273
1.177
3.532
Target 3
85
297
339
192
1.741
2.796
100
1.246
3.286
115
1.285
1.268
462
1.189
Target 4
117
309
357
376
2.286
3.017
188
1.704
4.054
114
1.356
1.372
374
1.137
The supematants harvested represent 50% of the total volume.
Prior to the meeting a Standard set of
ryopreserved lymphocytes from four
ndividuals had been distributed from
Varhus and tested by Iocal techniques
Kristensen 1978) accordingto the protocol
iutlined in Table 1. Inducer cultures for
cytotoxic cells were establtshed in a
checkerboard fashion using cells sensitized
in all possible allogeneic combinations.
Twelve effectors were thus generated and
tested against the target cells from the
same individuals. Data thus obtained were
submitted in three different forms: as raw
counts per minute (cpm) of lCr released
from labeled target cells; as release percent-
ages and as positive or negative assignments.
Thereafter the data were subjected to com-
bined analysis in Aarhus. The results are
summarized below:
a) Ra-w data — cpm
At the outset major differences were noted
in levels of cpm of 51Cr in the target cells
tested at different centers. This is illustrated
in Table 2 in which variations can be seen
not only in the overall level of counts but
also in the increment between different
reference values; for example, the increment
between maximum (by mechanical disrup-
tion) and total counts (in 104 cells) in the
data from Münich is negligible compared to
others. The absence of a total cpm value in
the Oslo data if due to difference in tech-
nique (see foomote, pp. 82—83).
Both the vaw data and the release per-
centages (for calculation see below) were
subjected to an analysis of variance in
which the following questions were asked:
a) was there a significant difference in
the way in which different laboratories
haadled their effector cells?
b) was there a significant difference in
the way in which different laboratories
handled their target cells?
c) was there a significant difference in
the way in which effector cells interacted
with the targets? This of course was to be
expected since this reflected the biology of
the CML.
Table 3Α
3-way analysts of vanance of CPM data
Log10 transformed data
Source of Variation
1) Main effects
Laboratories
CTLs
Targets
2) First order interactions
Laboratories X CTLs
Laboratories X targets
CTLs X targets
i 3) Second order mteraction
Laboratories X CTLs X targets
4) Total
df
4
11
3
44
12
33
132
239
SS
29 6
84 6
1 3
1376
99 3
585 6
196 1
1145 1
vanance
component
2 58%
7 39%
1 07%
12 02%
8 67%
51 14%
17 13%
MS
7 4
7 7
4 1
3 1
8 3
17 6
1 5
F Ρ
2 1 *·«
5 5 ·*»
11 7 * · *
F
o 001 (44,132) = 1 84 Fo M1 (12,132) = 2 74, Fo M1 (33,132) = 1 99
When data from the five centers were
analyzed these questions were affirmative
(Table 3A) However, when the Oslo data
were excluded only (b) and (c) remained
sigmficant The four remaimng laboratones
thus handled their effector cells in a similar
way, but all five laboratones differed in the
manner in which they handled target cells
Major sources of Variation in target cell
preparation and use are discussed below
b) Release percentages
The general formula used for these calcu-
lations in all laboratones was
E-S
M — S
•X 100 = Release Percent
where Ε IS cpm of the expenmental test
combination, S is cpm of the spontaneous
release from the target cell incubated in
medium alone, Μ is cpm of the maximal
Table 3B
3-way analysts of vanance 11
Log10 transformed data (Oslo results excluded)
Source of Variation
1) Main effects
Laboratones
CTLs
Targets
2) First order interactions
Laboratones X CTLs
Laboratones X targets
CTLs X targets
3) Second order mteraction
Laboratories X CTLs X target?
4) Total
df
3
11
3
33
9
33
99
191
SS
28 8
2254 5
39 3
95 7
44 1
1313 4
203 1
1978 9
vanance
component
1 5%
12 9%
2 0%
4 8%
2 2%
66 4%
10 3%
MS
9 6
23 1
13 3
2 9
4 9
39 8
2 6
F
1 1
1 1
1 9
15 3
Ρ
η s
*
• ·*
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Table 4
Release percentages of negative and positive effector and target cell combmations
Center
Category Effector Target Aarhus Leiden Marseille
0
0
0
nt
0
0
0
0
0
nt
nt
nt
25
12
22
9
8
15
22
18
20
14
6
9
München
ι
— 1
— 1
0
1
1
1
1
1
2
2
1
21
25
29
23
19
5
47
49
23
39
43
22
Oslo
12
11
13
4
nt
nt
7
-6
2
2
1
11
18
15
21
6
3
5
98
10
15
34
16
14
Negative
Positive
1/2
1/3
1/4
2/1
2/3
2/4
3/1
3/2
3/4
4/1
4/2
4/3
1/2
1/3
1/4
2/1
2/3
2/4
3/1
3/2
3/4
4/1
4/2
4/3
15
8
16
5
9
9
0
4
2
3
7
5
52
59
75
50
33
17
80
61
51
62
34
39
5
44
nt
0
1
0
-1
0
0
0
— 2
0
38
14
nt
19
8
18
48
42
18
29
19
9
release obtained after detergent solubdi-
zation of the target cells
Calculations by this procedure might
have been expected to correct for some of
the vanations between individual Centers
such as the overall level of cpm registered
and Variation due to target cell preparation.
The effectiveness of this correction is
ülustrated by the 12 positive and 12
negative control values shown in Table 4
Despite this correction, low positive and
high negative control values were some-
times observed The test values also showed
marked differences between centers as
ülustrated by the ranking Order of release
percentagts (Table 5), but these were
nevertheless highly sigmficantly associated
(P< 0.001)
Thf totals of the ranking Order for each
cell dre hsted in the nght hand column and
these were used for further classification of
reactions into positive, negative and inter-
•nediate groups (see below)
c) Speciftcity oflysts
The serologically defined phenotypes, both
HLA and non-HLA, which were present on
the pnming cells but not on the effector
cells are listed in Table 1 If these are the
targets for kilhng in the CML assay then
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Table 5
Ranking order of release percentages
Effector
2/4
4/2
2/3
3/2
2/1
4/2
3/4
1/2
3/1
1/4
2/1
1/3
4/1
4/1
2/3
4/3
2/4
4/3
2/1
2/3
4/3
2/4
3/2
3/1
4/1
3/4
2/3
3/2
2/4
3/1
1/2
4/3
2/1
3/4
4/2
1/2
4/2
1/4
1/3
1/3
1/3
1/4
3/4
3/2
1/2
4/1
3/1
1/4
Target
2
4
2
3
2
3
3
1
3
1
3
2
4
3
1
4
1
2
4
4
1
3
4
4
2
1
• 3
1
4
2
3
3
1
2
1
4
2
3
3
4
2
2
4
2
2
1
1
4
Aarhus
5.5
8
5.5
14
9.5
23
16
2
18
1
21
7
15
19
4
11
3
12
20
25
9.5
27
22
28
24
17
32
13
29
30
34
35
38
31
26
36
33
42
43
45
37
39
40
44
41
46
48
47
Leiden
12.5
2
8.5
8.5
8.5
2
8.5
16.5
4.5
N.T.
12.5
15
8.5
2
22.5
8.5
31
14
16.5
18.5
28.5
24.5
20.5
18.5
Marseille
NEGATIVE
5.5
N.T.
5.5
5.5
N.T.
5.5
5.5
5.5
5.5
5.5
5.5
5.5
N.T.
21
13
N.T.
15
15
N.T.
11.5
15
23.5
18
11.5
INTERMEDIATE
4.5
33
20.5
24.5
34.5
26.5
37
22.5
37
31
40.5
39
37
N.T.
31
26.5
28.5
N.T.
34.5
43
42
40.5
44
N.T.
23.5
18
25
18
35
21
27.5
27.5
27.5
30
POSITIVE
27.5
40
21
35
31.5
35
31.5
37
39
38
43
33
41.5
41.5
München
1.5
17
10
10
3.5
10
10
1.5
10
10
20
10
17
20
10
10
3.5
17
22.5
30
10
20
27.5
27.5
31
10
33
25
22.5
32
25
37.5
39.5
29
34
25
46
37.5
41
35.5
43
42
39.5
48
35.5
45
47
44
Oslo
N.T.
5.5
N.T.
2
10
5.5
7.5
26
16
27.5
1
24
7.5
3
18.5
24
24
30
13
11.5
36
4
13
18.5
33
38.5
9
44
11.5
30
18.5
30
13
36
38.5
27.5
36
18.5
33
41
42.5
21.5
33
21.5
40
45
46
42.5
Summed Ranl
(33.3)C
(36.0) C
(39.3)C
40.0 C
(42.0) C
46.0
47.5 C
51.5 C
54.0 C
(58.7) C
60.0
61.5
(64.0) C
65.0
68.0
(71.3)C
76.5
88.0
(96.0)
96.5
99.0
99.0
101.0
104.0
116.0
116.5
119.5
124.5
132.5
139.5
142
152.5
155
157
166.5
167.5
173.0
(177.3)
179.5
181.0
182.5
(186.0)
186.0
194.5
201.5
209.5
226.5
(233.3)
( ) estimated. C = autologous control.
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one would anticipate that the level of CML
observed would be a summation of the
effect of individual clones directed to each
individual antigen Thus a correlation
would be expected between the number of
phenotypes regarded by the effector cell as
foreign which were shared between the
pnming cell and the eventual target cell
No such correlation was found for the
non-HLA phenotypes (Table 6) However,
a significant correlation was found between
the summed rank and the number of
defmed HLA specificities (R = 0 79) This
suggested that the majonty of the targets
coded for were associated with the HLA
region, but one could not conclude from
these data that the serologically defined
specificities were the actual targets for
lysis - an assumption which until recently
ha? dominated the immunogenetics of
CML
Clear discrepancies are apparent in the
data shown in Table 6 where lt can be seen
that several combinations in which one
would expect positive CMLs through
serologically defmed HLA antigens gave
negative results By contrast, two combi-
nations (4/1 tested on 2 and 4/2 tested on
1) gave positive CMLs in the absence of
any known serologically defined HLA
antigen These data therefore suggest that
the targets for CML, performed with virgin
cells pnmed in vitro, are coded for in the
HLA region but that they do not belong to
the group of antigens classically defined by
serological techmques
d) Qualitative data — positive and negative
assignments
In the absence of any guidehnes, arbitrary
rules were apphed by each center for the
categonzation of release percentages mto
negative (—), mtermediate (±) and positive
(+) groups Although patterns of data so
denved were interpretable at the center of
origin, they were virtually useless when
compansons were made between centers
To overcome this problem the data were
reassigned into three groups based on the
summed ranks shown in the nght hand
column of Table 5 Reactions were classified
into negative (summed ranks from 5 to
110), mtermediate (111—160) and positive
(161—240) and the values for each were
reexpressed as release percentages in
Table 7 In other words, the mean ranking
order from the five centers was taken as
the basis for positive and negative assign-
ments All data were from tests in which
the effector to target ratio was 50 1
When the release percentages m each
group were plotted as a frequency distri-
bution and were exammed for their distn-
bution about the 10% value a relatively
clean Separation could be made between
the negative and positive CMLs (Table 8)
Intermediate CMLs however were spread
almost equally above and below the 10%
cut off pennt implying that individual
assignment« based on release percentages
were a relatively inaccurate way of cat-
egonzing CMLs especially those falling
in the Mtermediate ränge of activity Use
of data denved from a ddution curve
migbc allow a more accurate assignment
(sec below)
Despite these drawbacks significant
correlations were observed between nearly
all test values obtained in different centers
When the mtermediate CMLs were included
with positive CMLs all correlation coef-
ficients were lower (Table 9)
The 'grey area' of mtermediate values
may to some extent be attrlbutable fo
technical problems since the r^producibility
of the test compared at one center showed
suboptimal correlations (Table 10)
80
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Table 7
Release percentages of CML tests assigned to negative, mtermediate and positive categories on the
basis of summed ranks
Summed
5-110
Ar
- 1 5
— 8
- 1 6
— 5
5
3
- 9
- 9
13
- 1 3
- 9
1 4
0
15
4
5
- 2
- 3
- 3
8
— 7
- 5
- 5
- 5
Negi
ranks
Le
5
4
n t
0
1
5
9
0
7
14
1
1 0
— 1
7
0
8
0
- 2
0
- 2
- 2
13
3
0
itive
Ma
n t
0
0
n t
0
n t
3
0
1
4
0
7
0
1
0
5
0
6
n t
0
n t
4
4
n t
Mu
— 1
1
1
0
3
5
1
n t
13
0
γ
3
1
8
1
8
1
3
2
1
2
1
2
1
Os
12
11
13
4
7
6
9
n t
5
11
n t
— 2
7
9
— 6
6
2
j
2
1
1
16
14
1 1
C
C
C
C
C
c
c
c
c
c
c
c
Intermediate
1 1 1 - 1 6 0
Ar
35
50
33
17
19
— 5
0
23
11
39
Le
19
19
8
18
1 2
1 0
15
14
- 1
9
Ma
9
9
8
15
6
5
5
10
7
9
MU
7
23
19
5
17
7
1
11
16
22
Os
9*
6·
3*
5*
1 4
2 5
1 7
16
15
1 4 '
161-240
Ar
52
4 7
48
39
6 2
51
59
75
8 0
6 1
51
6 2
13
34
Le
38
2 1
13
14
12
n t
n t
n t
48
42
18
29
29
19
Positive
Ma
2 5
2 1
12
12
15
17
15
2 2
22
18
20
14
9
6
Mu
21
7
2 8
25
21
2 8
22
29
47
49
23
39
2 0
43
Os
18*
13
21
15*
2 0
1 0
9
21·
98*
1 0 *
1 5 *
3 4 *
17
16*
C Negative Control.
* Positive Control.
The standardized technique
Attempts to introduce standardized tech-
mques lead to early obsolescence! Never-
theless, for multicenter collaborative studies
of the type envisaged, where the goal is to
develop a practical system of phenotyping
Table 8
Proportion of mdividual release percentages
Negative Controls
Positive Controls
Negative CML's
Intermediate CML's
Positive CML's
< 10%
93%
17%
84%
44%
1 1 %
> 10%
7%
83%
16%
66%
89%
target cell antigens by the CML technique,
they are essential. Further progress seemed
to have been made toward this end and only
minor deviations were identified from
those reported at the preceeding Workshop
(Kristensen 1978). Discussions relating to
this uniform technique are summarized
below.
Footnote on tbe Oslo technique
This One step' CML technique has certain
features which result in a quantitative Variation in
release percentages when compared to those
obtained with the standardized technique. The
technique is simple and can be performed with
relatively few cells — an advantage to be con-
sidered for the application of the CML technique
CML TYPING STANDARDIZATION
Table 9
Matnces of release percentages of cell values front all Centers
Aarhus Leiden Marseille München Oslo
termediate excluded
arhus
:iden
arseille
unchen
slo
—
69
71
83
43
42
··
42
··
63
—
56
ο··58 38
itermediate mcluded with positive
arhus
eiden
arseille
unchen
slo
ilculation
given
X2 =
r —
Λ
of r
n i
/Ü
/ Ν
63
65
79
29
+
+ a
— c
n i
N x ( a d - b c ) 2
Χ η 2 Χ Ν, Χ
b Ν
d Ν
n 2
N 2
39
42
48
—
53
39 19
*
2
 without Yates correccion)
ι a clinical context (e g for horizontal studies of
enal allograft rejection) Details of this technique
ave been published elsewhere (Hirschberg et al
977) In bnef, it invoives the incubation of
^mphocytes with stimulator cells in wells of
iicrotiter plates At 6 days 51 Cr-labeled, PHA
ransformed target cells are added to the wells
nd the supernatants are harvested after 4 h and
ounted in the dassical manner This technique
loes not, at present, allow for the accurate adjust-
nent of the concentration of effectors prior to
he lysis assay The results obtamed, therefore,
re not yet directly comparable with those
>btamed frorrt the standardized technique us »1 in
other lsboratones Further developments which
might, for mstance, lead to the better quantitation
of the effector population may allow lts wider
apphcation in future collaborative studies
The group agreed that, for the time being, this
technique was not fulfilling the goals set for the
Workshop Recent mvestigations revealed that
when decreasing numbers of responder cells are
set up on day Ο a linear relation was obtamed
between this and the % release on day 6 This
implied that the cell concentrations m the plates
were not limiting cell growth (Pfeffer, personal
communication)
OrVrt.J_/JL,C I C 1 /Λ.1.,.
Table 10
Pairwise correlattons showtng reprocudicihty ofassignments in one center
+ + + — — + π ι
Aarhus
original
Aarhus
original
Aarhus
fresh
Aarhus
frozen I
Aarhus
fresh
Aarhus
frozen I
Aarhus
frozen I
Aarhus
frozen II 14 22
15
35
0.73
5
21
0
9
0
0
5
14
10
44
1.00
0.65
0.71
a) Inducer cultures
Primary cultures were incubated in plastic
flasks (e.g. Falcon 3013) at a concentration
of 0.5 x 106 responder cells (R) per ml
with a minimum of 20 ml of tissue culture
medium (TCM) per flask, i.e. 10 χ IO6R +
10X10 6S in 20 ml. The number of
responders to stimulators (S) was standard-
ized at a ratio of 1:1 and a suitable radiation
dose was considered to be 2,500 R. When
smaller quantities of effector cells were
required, trays with 2 ml wells (e.g. Costar
3 524) could be used in which 2X 106
responder cells and 2 x 10 stimulators
were cultured in 2 ml of TCM.
b) Target cultures
Two factors were considered of overriding
importance: first, batch Variation in the
PHA used to generate the blast cell targets,
and second, Variation in the specific activity
of the sodium 5 1 chromate (5 1 Cr) used for
labeling. Several batches of purified PHA-m
product (Difco, Co.) gave elevated levels of
killing in the autologous control combi-
nations, thus batches should be screened
for several criteria including optimal Stimu-
lation, as measured by tritiated thymidine
incorporation on day 3, low spontaneous
release after labeling with s l Cr, high
maximum incorporation of 5 1 Cr label, low
level of autologous killing, and lack of
clump formation. On the basis of these
criteria the best batch and dilution of PHA
can be selected.
Specific activities of sodium 5 1 chromate
batches vary widely (50—600mC/mg).
When the specific activity is low, poor
labeling ensues and unreliable results are
obtained. An optimal specific activity was
considered to be 300—500mC/mg, used at
a concentration of 5 mC/ml. It was sugges-
ted that more reliable results may be
obtained with low activity chromium if
the target cells are labeled for prolonged
periods (e.g. overnight). In order to free
the cells of unincorporated label sticking
to dead cells or cell debris the labeled cells
can be centrifuged over Ficoll Hypaque
(Sp.g.1.077) for 20min at 400g.
c) Lysis cultures
Differences existed between the laboratories
with regard to the culture vessel used
(tubes or microplates) and the shape of the
microtiter well (UorV). However, no clear
advantages were apparent except that
V-shaped wells apparently gave more
reproducible results than U-shaped micro-
titer wells. When using tubes, both pellet
and supernatant could be counted and each
set of data included in the calculation of
release percentages. Lysis cultures con-
ducted in microtiter wells could be har-
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vested using adsorbent plugs marketed by
Flow Laboratories (Hirschberg et al 1977)
or by a 'home made' 96 multisample har-
vester which was easy to construct and was
m routine use in Marseille (Mawas, personal
communication)
With regard to the 'maximum release
control' differences apparently existed
depending on the detergent used For
instance, Saponin (like freeze thawing)
regularly gave maximum release values that
were 20% less than the total label mcorpor-
ated On the other hand Triton X used in
Munich was found to release s l Cr which
approximated to the total cpm in the
culture, thus contradicting the concept of a
maximal amount of releasable isotope
which IS less than the total incorporated
It was recommended that an assay be
performed with at least four effector to
target ratios, including 50 1, 25 1, 12 5 1,
6 25 1 However, it was not essential to
adhere precisely to these points since very
rehable results were obtained when any
senes of 2-fold dilutions of effectors were
set up (Mawas, personal communication)
d) Data analysis
At present neither theoretical consider
ations nor expenmental analysis favors use
of one method for analysis of data obtained
from chromium release assays Several
effective routines in common use have
been estabhshed but they are based on
Intuition and individual expenence For
the analysis of data obtained from a multi-
center collaborative study it is essential
that a uniform method be developed and
to achieve this goal each assumption
pertainmg to the test will need to be
subjected to formal testing
The analysis can be considered to have
three different levels of complexity the
problem of rephcation, the problem of
quantitation of cytolysis and the com-
panson of dose-response relationships
ι) Rephcation
When considering values denved from a
senes of rephcates it should be born in
mind that the higher the level of activity
(cpm) the higher the vanance (Jensen et al
1977) This rrnphes that unless math-
ematically transformed data (e g Square
route cpm) are considered no Single level of
acceptable vanance can be used for values
at all levels of cpm
Untü now the Workshop has addressed
ltself to the question of rephcate expen-
ments performed between different centers,
it has not considered the problems of
replicatjon of results obtained from Single
effectors and targets and between rephcate
expenments performed withm individual
centers
u) Cytolysis
The quantitation of cytolysis denved
from Single dose assays has long been
assumed to be influenced by two major
variables, namely the spontaneous release
of the labeled target cell and the maximum
release of the target cell Thus the following
general formula has been widely used
E - S 100
X = Q Crelease percentage),
where Ε κ the expenmental value, S the
spontaneous and Μ the maximum release
in cpm The assumptions in this calculation
require further critical testing both for
their inherent vahdity (ι e that Ε is not
independent of Μ & S) and for the vahdity
of the corrections proposed This has been
succinctly cnticised elsewhere by others
(Stulting & Berke 1973)
In an attempt to further normahze
Single dose data so that rephcate data sets
can be pooled, it has been suggested that
the release percentages can be further
corrected by relating them to the positive
control value (B). Thus:
Q
— X 100 = % RCR (percent relative
cytolytic response).
However, it appears that the variance of
% RCR increases with the level of the %
RCR, thus rendering indiscriminate pooling
of such data invalid (Schendel et al. 1979b).
Some general criticisms of all these
manoevers are that they
a) lose Information by failing to utilize
a large proportion of the data generated,
b) make assumptions which may be
biologically invalid,
c) do not readily allow one to compare
two values for the sigmficance of the
differences between them.
lii) Dose-response
Analysis of data obtained at several
different dose levels (in this case a constant
number of targets with a variable number
of effector cells) generates much more
Information than can be obtained from
Single independent values. Α dose response
curve, in which an appropriate expression
of the cytolysis value on the ordinate is
plotted against the effector cell dose on the
axis, follows a sigmoid curve which rises
to a plateau beyond which no further Cr
release occurs.
One proposed method by which groups
of such data can be compared is by the
calculation of lyticunits (L.U.) as originally
described by Cerottini & Brunner 1971.
This is simply a method of ranking the
effector to target cell combinations accord-
ing to the relative number of effector cells
needed to achieve a comparable amount of
cytolysis.
Α more sophisticated and theoretically
more acceptable method is that of linear
regression analysis (Simpson et al. 1975).
This allows sets of data to be compared for
the significance of their difference. By
linear regression analysis the best fitting
curve can be defined with its Standard
deviation for each set of data, allowing
comparisons with other data sets to deter-
mine which values differ significantly from
each other. It is anticipated that such com-
parisons would form the basis of a more
sensitive comparison between different
effector and target cell combinations.
In addition dose response analysis
would allow one to identify reactions in
which only a subpopulation of the target
cells was killed (e.g. Β cells), in which case
a plateau of killing would be observed
when the number of target cells became
limiting.
e) Freezing and thawing
Innovations in this area were few, but in
the experience of most workers good results
could be obtained with the simplest of
freezing techniques. For example satis-
factory recovery of functional activity was
obtained with the 'Drop Freezing' method
in which ampoules containing lymphocytes
suspended in freezing medium (TCM with
10% DMSO) and 20% plasma were placed
in a cardboard box inside a —80 freezer,
for at least 60' prior to transfer to liquid
nitrogen.
Thawing procedures varied slightly but
probably did not account for difference in
CML results obtained between different
centers.
Two centers feit that when using
frozen/thawed fresh or sensitized cells a
recovery period was necessary during
which time the cells could recover their
lytic function. At least 2 h in complete
TCM at 37° C in 5% CO2 was required.
The percentage viable cells as estimated
by dye exclusion following thawing is
always an underestimate of the functional
capacity recovered from thawed cells and
a simple method termed 'the curve shift
method' was proposed for making more
accurate assessments of recovered func-
tional capacity of frozen thawed lympho-
cyte populations (Lambalgen et al. 1979).
Τ cell expansion techniques
In the absence of techniques for the
continued growth and expansion of Τ killer
cell populations CML typing would be
limited to studies involving small panels of
individuals. The introduction of techniques
whereby Τ cell populations can be expanded
up to 1,000-fold within a period of 4 to 6
weeks opens new horizons, allowing
virtually limitless production of cellular
typing reagents. In practice the current
methods are laborious. They rely on the
restimulation of the effector cells by one
of three different reagents: firstly, con-
ditioned medium prepared from the super-
natants of lymphocytes stimulated with
mitogens or foreign lymphocytes (Morgan
et al. 1976, Bonard et al. 1978, 1979,
Strausser & Rosenberg 1978, Schendel
et al. 1979a); secondly, pokeweed mitogen
(Charmot et al. 1975, 1979), and thirdly,
repeated Stimulation at specified intervals
by cells of the original stimulator pheno-
type (Macdonald et al. 1974, Svedmyr
1975).
Typing by cold target Inhibition
An additional means of phenotyping by
the CML technique uses the so called 'cold
target Inhibition' technique. This involves
the competitive Inhibition of killing of the
5 1
 Cr labeled target cells by addition of an
appropriate number of unlabeled cells
which share some of the determinants with
the labeled target cells. Such a technique
allows complex killing reactions to be
dissected on the basis of specificities
involved. In addition, cells of certain
phenotypes may not be directly lysed but
may have the ability to competitively
inhibit a reaction, thus leading to a wider
understanding of the interaction between
the target molecule and the receptors on
effector cells.
Proposais for future cell exchange
It was considered appropriate that the next
CML Workshop again should limit itself to
the study of technical problems by a few
centers sharing the aim of estabhshing a
standardized CML technique capable of
generating comparable data.
Four aspects are to be considered:
— standardization of reagents,
— comparison of various Τ cell expansion
techniques,
— reproducibihty both within and be-
tween centers,
— comparison of methods of data analysis.
a) Standardization of reagents
In an attempt to control some variable
aspects of the inducer, target and cytolysis
cultures it was proposed that certain
reagents should be standardized so that one
batch wouid be distributed and used by all
centers. These reagents included serum and
cells (Aarhus), RPMI-1640 medium
(Munich), sodium Chromate (Munich),
Phytohemagglutinin (Munich), Pokeweed
Mitogen (Marseille) and Triton X 100
(Munich).
b) Comparison of Τ cell expansion
techniques
Four basic protocols are to be considered;
they are summarized as follows:
BRADLEY ET AL
protocol 1 Α + B
x
 +
2 (ABX 14 days) + B x
3 (ABX 14 days) + PWM
4 (Protocols 1, 2 & 3)
In protocol 1 thawed cells from individ-
uals 1 to 4 are to be set up in pnmary MLR
(Ratio Responders to Stimulators 1 1),
cultured for 6 days, and tested on a panel
of PHA transformed targets
In protocol 2 cryopreserved sensitized
cells are to be thawed, restimulated with
the original pnming cell (ratio 11), cultured
for an additional 5 days and tested on a
taiget cell panel
In protocol 3 cryopreserved sensitized
cells are to be thawed, cultured for 5 days
with Pokeweed Mitogen (1 in 100 GIBCO)
and tested on a panel of target cells
Protocol 4 lssimilar to 1, 2 and 3 except
that effector cells are mixed with cold
targets to determine Inhibition of panel
target cell lysis
Protocol 1 will be carned out in all five
centers, protocol 2 in Aarhus, Leiden and
Oslo, protocol 3 in Marseille and Mumch
and protocol 4 in Marseille
c) Reproductbihty
Reproducibihty between centers IS to be
retested by recirculating cells 1, 2, 3 and 4
(Table 1) for use in protocol 2 with the
addition of one cell as a blind rephcate
('cell 5') thus allowing reproducibihty
withm a center to be evaluated Since no
sigmficant differences existed between the
way in which centers handled effector cells
(Table 3B) cell 5 will only be circulated as
a target In addition lt is proposed to distn-
bute a Standard aliquot of sodium
chromate to be measured on a specified
^ (cells frozen in Aarhus and thawed in the appro
priate center)
Test
Test
Test
Cold Target Inhibition Tests
date so that the counter efficiency in each
center can be compared
Protocols 2, 3, 4 and 5 are to be tested
by distnbuting the combinations 1/2X,
1/3X, 1/4X, 4/l x, 4/2x and 4/3x (Table 1)
d) Methods of data analysis
Raw cpm data denved from tnplicate tests
are to be submitted for four consecutive
dilutions of effector (e g E T ratlos of
50 1, 25 1, 12 5 1 and 6 25 1) In addition
the appropnate data relating to spontaneous
and maximum release cpm are to be
collected
Data relating to cell yield in pnming
cultures are also to be collected
The crude cpm data will then be further
analyzed along the guidelines listed above
Techmques for future consideration
Attention was directed to alternative
methods of labeling, mcluding the 75Se
method introduced by Leibold which is
ideally suited for lymphoblastoid cell hne
targets (Leibold & Bridge 1979) and the
carboxyfluorescein diacetate method intro
duced by Bruning which is safe (no radio-
activity required), needs fewer cells and
can readily be automated (Brumng et al
1980)
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